These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8603522)

  • 1. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
    Levy Y; Labaume S; Colombel M; Brouet JC
    Clin Exp Immunol; 1996 Apr; 104(1):167-72. PubMed ID: 8603522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells.
    Smith MR; Xie T; Joshi I; Schilder RJ
    Br J Haematol; 1998 Sep; 102(4):1090-7. PubMed ID: 9734662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
    Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF
    J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors.
    Sidell N; Taga T; Hirano T; Kishimoto T; Saxon A
    J Immunol; 1991 Jun; 146(11):3809-14. PubMed ID: 2033252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction.
    Ogata A; Nishimoto N; Shima Y; Yoshizaki K; Kishimoto T
    Blood; 1994 Nov; 84(9):3040-6. PubMed ID: 7949175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
    Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
    Leuk Res; 1996 Apr; 20(4):291-301. PubMed ID: 8642840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites.
    Chen YH; Desai P; Shiao RT; Lavelle D; Haleem A; Chen J
    Blood; 1996 Jan; 87(1):314-23. PubMed ID: 8547658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes.
    Zancai P; Cariati R; Quaia M; Guidoboni M; Rizzo S; Boiocchi M; Dolcetti R
    Int J Oncol; 2004 Aug; 25(2):345-55. PubMed ID: 15254731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
    Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
    Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rosiglitazone and all-trans retinoic acid inhibit human myeloma cell proliferation via apoptosis signaling pathway modulation].
    Huang HW; Wu DP; Chen GH; Chang HR; Chow HC; Leung AY; Liang R
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):242-6. PubMed ID: 19731824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
    Kovacs E
    Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
    Sammons J; Ahmed N; Khokher MA; Hassan HT
    Stem Cells; 2000; 18(3):214-9. PubMed ID: 10840075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
    Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
    Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
    Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells.
    Tosi P; Pellacani A; Visani G; Ottaviani E; Ronconi S; Zamagni E; Benni M; Cavo M; Tura S
    Eur J Haematol; 1999 Mar; 62(3):143-8. PubMed ID: 10089890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.
    Brocke-Heidrich K; Kretzschmar AK; Pfeifer G; Henze C; Löffler D; Koczan D; Thiesen HJ; Burger R; Gramatzki M; Horn F
    Blood; 2004 Jan; 103(1):242-51. PubMed ID: 12969979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the biological activity and molecular mechanism of IFNalpha on human myeloma cell line Sko-007].
    Song L; Li Y; Sun Y; Shen B
    Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):517-9. PubMed ID: 12482347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategies.
    Villunger A; Egle A; Kos M; Hittmair A; Maly K; Greil R
    Int J Cancer; 1996 Feb; 65(4):498-505. PubMed ID: 8621234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-21 is a growth and survival factor for human myeloma cells.
    Brenne AT; Ro TB; Waage A; Sundan A; Borset M; Hjorth-Hansen H
    Blood; 2002 May; 99(10):3756-62. PubMed ID: 11986233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.